Proprietary Notice

General Terms: InterQual^®, InterQual^® Connect products, including the clinical content (“Clinical Content”, collectively the “Work”) contains confidential and trade secret information of Optum, Inc. and/or one of its subsidiaries or affiliates (“Optum”), and is provided to licensees who have an existing license agreement in force only under the time-limited license as provided under that license agreement. Licensee and any recipient thereunder shall use the Work in accordance with the terms and conditions of the license agreement..

If You Have Been Provided Access for Evaluation Purposes: Optum is the owner/licensor of the Work. Optum has prepared the Work for exclusive use of its licensees of software applications embodying the Clinical Content. The Work contains confidential and trade secret information of Optum and, if you have been provided access to the Work for evaluation purposes only, is provided to you only under a nontransferable, nonexclusive license whose term is limited to the time frame set forth in the email notification sent to you containing your access password. You and any recipient hereunder shall use the Clinical Content in accordance with the terms and conditions of this license and the email notification. You are granted this license solely for the purpose of your internal evaluation of the Work as part of your decision whether to license the Work, and for no other purpose. You expressly agree to keep the Work confidential and not to release or disclose the Work to any other third person without Optum's express written permission. Further reproduction, including but not limited to the printing of any portion of the Work or results obtained as part of the permitted evaluation, adaptation, incorporation into other media, and release of the Work by you is strictly prohibited except upon prior written permission of an officer of Optum. Notwithstanding the foregoing, any copies or reproductions of the Work made by you during the limited evaluation term shall be destroyed and shall not be used for any purpose upon the expiration of the term.

Proprietary Notice: The Work is protected under United States and international copyright and other intellectual property laws. If this Work is delivered pursuant to a federal government contract that requires the conveyance of rights in data to the government, it is understood that the Work, including commercial software, clinical content, third-party software, documentation and/or other technical data, was developed exclusively at Optum's private expense, and that Optum will convey only limited or restricted rights in the Work to the government consistent with the guidance set forth in the Federal Acquisition Regulation (“FAR”) and/or FAR Supplements. Conveyance of any additional rights beyond limited or restricted rights in the Work requires Optum’s express consent contained in a separate written agreement.

No portion of this publication may be copied, reproduced, or incorporated into any other media without Optum’s prior written consent

Acknowledgments and Disclaimer: The Clinical Content is developed by Optum’s clinical research staff which includes physicians, registered nurses, and other healthcare professionals. Many of Optum’s clinical staff hold advanced degrees and case management certification. The Clinical Content is reviewed and validated by a national panel of clinicians and medical experts, including those in community and academic practice settings, as well as within the managed care industry throughout the United States. The Clinical Content is a synthesis of evidence-based standards of care, current practices, and consensus from licensed specialists and/or primary care physicians.

The Clinical Content reflects clinical interpretations and analyses and cannot alone either resolve medical ambiguities of particular situations or provide the sole basis for definitive decisions. The Clinical Content is intended solely for use as screening guidelines with respect to the medical appropriateness of healthcare services and not for final clinical or payment determinations concerning the type or level of medical care provided, or proposed to be provided, to a patient.

THE WORK IS PROVIDED “AS IS.” OPTUM DISCLAIMS ANY OTHER WARRANTY, EXPRESS OR IMPLIED, INCLUDING AS TO MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE OR SERVICE OF THE WORK, OR THE COMPATIBILITY OF OUTPUT USING THE WORK WITH ANY LAW, REGULATION, OR ORDER. IN NO EVENT SHALL OPTUM BE LIABLE FOR SPECIAL, INCIDENTAL, CONSEQUENTIAL, OR EXEMPLARY DAMAGES IN CONNECTION WITH, OR ARISING OUT OF, ANY USE OF THE WORK

Trademarks: InterQual^® and InterQual^® Connect are trademarks of Optum, Inc. and/or one of its subsidiaries and affiliates. All other trademarks are the property of their respective owners.

Patents: This product may be covered by one or more pending or issued patents.

Third Party Notices:

AMA CPT^® Codes: The Work may incorporate the CPT^® terminology developed and copyrighted by the American Medical Association (“AMA”). The CPT codes and terminology are provided pursuant to a license agreement between Optum (or one of its affiliates) and the AMA.

CPT copyright 2012-2023 American Medical Association. All rights reserved. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein. CPT is a registered trademark of the American Medical Association. Applicable FARS/DFARS Restrictions Apply to Government Use.

U.S. Government Rights

The Work includes CPT which is commercial technical data and/or computer data bases and/or commercial computer software and/or commercial computer software documentation, as applicable, which was developed exclusively at private expense by the American Medical Association, AMA Plaza, 330 North Wabash, Suite 39300, Chicago, Illinois, 60611-5885. U.S. Government rights to use, modify, reproduce, release, perform, display, or disclose these technical data and/or computer data bases and/or computer software and/or computer software documentation are subject to the limited rights restrictions of DFARS 252.227-7015(b)(2) (November 1995) and/or subject to the restrictions of DFARS 227.7202-1(a) (June 1995) and DFARS 227.7202-3(a) (June 1995), as applicable, for U.S. Department of Defense procurements and the limited rights restrictions of FAR 52.227-14 (December 2007) and/or subject to the restricted rights provisions of FAR 52.227-14 (December 2007) and FAR 52.227-19 (December 2007), as applicable, and any applicable agency FAR Supplements, for non-Department of Defense Federal procurements.

BCBSA MPRM: The BCBSA Medical Policy Reference Manual (MPRM) is the proprietary and confidential information of Blue Cross Blue Shield Association. © 2001-2024 Blue Cross Blue Shield Association. All Rights Reserved. The MPRM content is licensed to Optum, Inc. and/or one of its subsidiaries.

NCCN Compendium: © National Comprehensive Cancer Network, Inc 2011-2024, All Rights Reserved. NATIONAL COMPREHENSIVE CANCER NETWORK^®, NCCN^®, NCCN GUIDELINES^®, NCCN TEMPLATES^®, and NCCN COMPENDIUM^® are trademarks owned by the National Comprehensive Cancer Network, Inc.

ASAM Criteria: The ASAM Criteria, Treatment Criteria for Addictive, Substance-Related, and Co-Occurring Conditions, Third Edition. Copyright © 2013-2024 American Society of Addiction Medicine (ASAM).

ASAM Criteria: The ASAM Criteria, Treatment Criteria for Addictive, Substance-Related, and Co-Occurring Conditions, Fourth Edition. Copyright © 2023-2024 American Society of Addiction Medicine (ASAM)..

Oracle JRE: Additional copyright notices and license terms applicable to portions of the software are set forth in the THIRDPARTYLICENSEREADME-JAVAFX file accessible at http://www.oracle.com/technetwork/java/javase/documentation/index.html. In addition to any terms and conditions of any third party open source/freeware license identified in the THIRDPARTYLICENSEREADME file, any applicable disclaimers of warranty and limitations of liability shall apply to the software in this distribution.

RJ Health Systems: This product includes content from RJ Health Systems International, LLC, © RJ Health Systems International, LLC.

Solution components: Any components listed in Exhibit A are distributed under the licenses identified therein.

Open Source

The following offer applies to items that are licensed under one of the following licenses or any other license that requires that source code for the item be made available by Optum with the Work: Common Development and Distribution License 1.0 and 1.1, Common Public License 1.0, Eclipse Public License v. 1.0, GNU Lesser General Public License v. 3, GNU Lesser General Public License v. 2.1, and SUN Public License Version 1.0. If the source code for the item was not included in the package you received or at the location referenced and you would like to obtain a copy, please contact Optum.

Open source components listed in Exhibit A are distributed under the licenses identified therein. The open source items may contain or reference other license and notice terms that apply in addition to the terms referenced below. In most instances the applicable license and notice files are included in the Work. If you are unable to locate the applicable license or notice for a particular item and you would like to obtain a copy, please contact Optum. Common licenses may also be found at https://opensource.org/licenses/alphabetical.

Permission is hereby granted, free of charge, to any person obtaining a copy of this software and associated documentation files (the "Software"), to deal in the Software without restriction, including without limitation the rights to use, copy, modify, merge, publish, distribute, sublicense, and/or sell copies of the Software, and to permit persons to whom the Software is furnished to do so, subject to the following conditions:

The above copyright notice and this permission notice shall be included in all copies or substantial portions of the Software.

THE SOFTWARE IS PROVIDED "AS IS", WITHOUT WARRANTY OF ANY KIND, EXPRESS OR IMPLIED, INCLUDING BUT NOT LIMITED TO THE WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE AND NONINFRINGEMENT. IN NO EVENT SHALL THE AUTHORS OR COPYRIGHT HOLDERS BE LIABLE FOR ANY CLAIM, DAMAGES OR OTHER LIABILITY, WHETHER IN AN ACTION OF CONTRACT, TORT OR OTHERWISE, ARISING FROM, OUT OF OR IN CONNECTION WITH THE SOFTWARE OR THE USE OR OTHER DEALINGS IN THE SOFTWARE.

Concurrent: All classes are released to the public domain and may be used for any purpose whatsoever without permission or acknowledgment. Portions of the CopyOnWriteArrayList and ConcurrentReaderHashMap classes are adapted from Sun JDK source code. These are copyright of Sun Microsystems, Inc, and are used with their kind permission, as described in this license.

“Java Software technologies” means classes/java/util/ArrayList.java, and classes/java/util/HashMap.java.

Sun hereby grants Doug Lea a non-exclusive, worldwide, non-transferrable license to use, reproduce, create derivate works of, and distribute the Java Software and derivative works thereof in source and binary forms as part of a larger work, and to sublicense the right to use, reproduce and distribute the Java Software and Doug Lea's derivative works as the part of larger works through multiple tiers of sublicensees provided that the following conditions are met:

-Neither the name of or trademarks of Sun may be used to endorse or promote products including or derived from the Java Software technology without specific prior written permission; and

-Redistributions of source or binary code must contain the above copyright notice, this notice and the following disclaimers:

This software is provided "AS IS," without a warranty of any kind. ALL EXPRESS OR IMPLIED CONDITIONS, REPRESENTATIONS AND WARRANTIES, INCLUDING ANY IMPLIED WARRANTY OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE OR NON-INFRINGEMENT, ARE HEREBY EXCLUDED. SUN MICROSYSTEMS, INC. AND ITS LICENSORS SHALL NOT BE LIABLE FOR ANY DAMAGES SUFFERED BY LICENSEE AS A RESULT OF USING, MODIFYING OR DISTRIBUTING THE SOFTWARE OR ITS DERIVATIVES. IN NO EVENT WILL SUN MICROSYSTEMS, INC. OR ITS LICENSORS BE LIABLE FOR ANY LOST REVENUE, PROFIT OR DATA, OR FOR DIRECT, INDIRECT, SPECIAL, CONSEQUENTIAL, INCIDENTAL OR PUNITIVE DAMAGES, HOWEVER CAUSED AND REGARDLESS OF THE THEORY OF LIABILITY, ARISING OUT OF THE USE OF OR INABILITY TO USE SOFTWARE, EVEN IF SUN MICROSYSTEMS, INC. HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH DAMAGES. You acknowledge that Software is not designed, licensed or intended for use in the design, construction, operation or maintenance of any nuclear facility.

iText: This product licensed under the Mozilla Public License, Version 1.1 (the “License”). See source files for copyright dates, reservation of rights and additional license information as licenses for individual files may vary. You may obtain a copy of the License at http://www.mozilla.org or at http://www.lowagie.com/iText/MPL-1.1.txt. Software distributed under the License is distributed on an “AS IS” basis, WITHOUT WARRANTY OF ANY KIND, either express or implied. See the License for the specific language governing rights and limitations under the License. The Original Code is iText. The Initial Developer of the Original Code is Bruno Lowagie. Contributor(s): all the names of the contributors are added in the source code where applicable.

MGOpen Canonica: Copyright © 2004 by MAGENTA Ltd. All Rights Reserved. Permission is hereby granted, free of charge, to any person obtaining a copy of the fonts accompanying this license (“Fonts”) and associated documentation files (the “Font Software”), to reproduce and distribute the Font Software, including without limitation the rights to use, copy, merge, publish, distribute, and/or sell copies of the Font Software, and to permit persons to whom the Font Software is furnished to do so, subject to the following conditions:

The above copyright and this permission notice shall be included in all copies of one or more of the Font Software typefaces. The Font Software may be modified, altered, or added to, and in particular the designs of glyphs or characters in the Fonts may be modified and additional glyphs or characters may be added to the Fonts, only if the fonts are renamed to names not containing the word “MgOpen,” or if the modifications are accepted for inclusion in the Font Software itself by each appointed Administrator. This License becomes null and void to the extent applicable to Fonts or Font Software that has been modified and is distributed under the “MgOpen” name. The Font Software may be sold as part of a larger software package but no copy of one or more of the Font Software typefaces may be sold by itself. THE FONT SOFTWARE IS PROVIDED “AS IS,” WITHOUT WARRANTY OF ANY KIND, EXPRESS OR IMPLIED, INCLUDING BUT NOT LIMITED TO ANY WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE AND NONINFRINGEMENT OF COPYRIGHT, PATENT, TRADEMARK, OR OTHER RIGHT. IN NO EVENT SHALL MAGENTA OR PERSONS OR BODIES IN CHARGE OF ADMINISTRATION AND MAINTENANCE OF THE FONT SOFTWARE BE LIABLE FOR ANY CLAIM, DAMAGES OR OTHER LIABILITY, INCLUDING ANY GENERAL, SPECIAL, INDIRECT, INCIDENTAL, OR CONSEQUENTIAL DAMAGES, WHETHER IN AN ACTION OF CONTRACT, TORT OR OTHERWISE, ARISING FROM, OUT OF THE USE OR INABILITY TO USE THE FONT SOFTWARE OR FROM OTHER DEALINGS IN THE FONT SOFTWARE.